| PUBCHEM ID |
71313230
|
| UNII |
8V40327H44
|
| Preferred Term |
CEFEPIME DIOXIME
|
| CAS |
|
| INCHIKEY |
KMTSWFKAQYRTIV-LANNWKMSSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CN1(CC(CS[C@H]2[C@H]3NC(/C(/c4csc(NC(/C(/c5csc(N)n5)=N\OC)=O)n4)=N\OC)=O)=C(C(O)=O)N2C3=O)CCCC1
|
| Total Surface Area |
468,75
|
| Relative PSA |
0,4986
|
| TPSA |
295,81
|
| cLogS |
-3,886
|
| MW |
664,767
|
| cLogP |
-0,2953
|
| H-Acceptors |
16
|
| H-Donors |
4
|
| Ro5 violations |
2
|
| Druglikeness |
19,335
|
| DrugScore |
0,490287074574538
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA-
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,3512
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Plasma membrane
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2996
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,6
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,3678
|
| Carcinogenicity (Three-class) |
Non-required
|
